Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry

Applied and Environmental Microbiology

Volumn 75, Issue 7, 2009, Pages 2027-2036

  Gates, Irina V ^a,c   Zhang, Yuhua ^a   Shambaugh, Cindy ^a,d   Bauman, Meredith A ^a,b   Tan, Charles ^a   Bodmer, Jean Luc ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Johns Hopkins University   (United States)

^c CENTOCOR INC   (United States)

^d MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

96 WELLS; BIOLOGICAL ACTIVITIES; FLOW CYTOMETRY ASSAYS; IN-VITRO; INFECTED CELLS; INFECTIVITY ASSAYS; LABOR INTENSIVES; LIMIT OF DETECTIONS; LIMIT OF QUANTIFICATIONS; LINEAR RESPONSE; LIVE VIRUS; MICROTITER PLATES; PLAQUE ASSAYS; QUANTITATIVE MEASUREMENTS; SEMI-AUTOMATED; SIGNAL-TO-NOISE RATIOS; VACCINE STRAINS; VARICELLA-ZOSTER VIRUS INFECTIONS; VISUAL INSPECTIONS;

BIOACTIVITY; CELL CULTURE; FLOW CYTOMETRY; SIGNAL TO NOISE RATIO; TISSUE CULTURE; VACCINES; VIRUSES; VISUAL COMMUNICATION;

ASSAYS;

LIVE VACCINE; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

BIOACTIVITY; BIOASSAY; DETECTION METHOD; ETIOLOGY; FLOW CYTOMETRY; GENE EXPRESSION; HOST-PATHOGEN INTERACTION; IMMUNIZATION; INFECTIVITY; PROTEIN; QUANTITATIVE ANALYSIS; SIGNAL-TO-NOISE RATIO; SKIN DISORDER; VACCINE; VIRAL DISEASE; VISUAL ANALYSIS;

ACCURACY; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROTITER PLATE ASSAY; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; TISSUE CULTURE; VARICELLA ZOSTER VIRUS; VIRUS ATTENUATION; VIRUS CULTURE; VIRUS INFECTIVITY; VIRUS STRAIN;

AUTOMATION; CELL LINE; CHICKENPOX VACCINE; FLOW CYTOMETRY; HERPESVIRUS 3, HUMAN; HUMANS; PLAQUE ASSAY; SENSITIVITY AND SPECIFICITY;

HUMAN HERPESVIRUS 3;

EID: 63849285257     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02006-08     Document Type: Article

References (34)

1. Arvin, A. M. 1996. Immune responses to varicella-zoster virus. Infect. Dis. Clin. N. Am. 10:529-570.
2. Bajpai, R., J. Lesperance, M. Kim, and A. V. Terskikh. 2008. Efficient propagation of single cells Accutase-dissociated human embryonic stem cells. Mol. Reprod. Dev. 75:818-827.
3. Bordignon, J., S. C. P. Ferreira, G. M. M. Caporale, M. L. Carried, I. Kotait, H. C. Lima, and C. R. Zanetti. 2002. Flow cytometry assay for intracellular rabies virus detection. J. Virol. Methods 105:181-186.
4. Casella, G., and R. L. Berger. 2001. A least squares solution, p. 581-583. Statistical inference, 2nd ed. Duxbury Press, Pacific Grove. CA.
5. Cohen, J. I., and H. Nguyen. 1997. Varicella-zoster virus glycoprotein I is essential for growth of virus in Vero cells. J. Virol. 71:6913-6920.
6. Diaz, C, P. Dentico, R. Gonzalez, R. G. Mendez, A. Cinquetti, J. L. Barben, A. Harmon, I. Chalikonda, J. G. Smith, J. E. Stek, A. Robertson, M. J. Caulfield, L. R. Biasio, J. L. Silber, C. Y. Chan, R. Vessey, J. Sadoff, L S. F. Chan, H. Matthews, W. Wang, K. Schlienger, and F. P. Schodel. 2006. Safety, tolerability. and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects ≥13 years of age. Vaccine 24:6875-6885.
7. Hambleton, S, S. P. Steinberg, M. D. Gershon, and A. A. Gershon. 2007. Cholesterol dependence of varicella-zoster virion entry into target cells. J. Virol. 81:7548-7558.
8. Insinga, R. P., R. F. Itzler, J. M. Pellissier, P. Saddier, and A. A. Nikas. 2005. The incidence of herpes zoster in a United States administrative database. J. Gen. Intern. Med. 20:748-753.
9. Jacquet, A., M. Haumont, D. Chellun, M. Massaer, F. Tufaro, A. Bollen, and P. Jacobs. 1998. The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans. Virus Res. 53: 197-207.
10. Kao, C. L., M. C. Wu, Y. H. Chiu, J. L. Lin, Y. C. Wu, Y. Y. Yueh, L. K. Chen, M. F. Shaio, and C. C. King. 2001. Flow cytometry compared with indirect immunofluorescence for rapid detection of dengue virus type 1 after amplification in tissue culture. J. Clin. Microbiol. 39:3672-3677.
11. Keller, P. M., B. J. Neff, and R. W. Ellis. 1984. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J. Virol. 52:293-297.
12. Kinchington, P. R., and S. E. Turse. 1998. Regulated nuclear localization of the varicella-zoster virus major regulatory protein, IE62. J. Infect. Dis. 178: S16-S21.
13. Krah, D. L., T. L. Schofield, and P. J. Provost. 1990. Enhancement of varicella-zoster virus plaquing efficiency with an agarose overlay medium. J. Virol. Methods 27:319-326.
14. Lambeth, C. R., L. J. White, R. E. Johnston, and A. M. de Silva. 2005. Flow cytometry-based assay for titrating dengue virus. J. Clin. Microbiol. 43:3267-3272.
15. Lirwin, V., M. Sandor, and C. Grose. 1990. Cell-surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology 178:263-272.
16. Lonsdale, R., M. G. Pau, M. Oerlemans, C. Ophorst, A. Vooys, M. Havenga, J. Goudsmit, F. UytdeHaag, and G. Marzio. 2003. A rapid method for immunotitration of influenza viruses using flow cytometry. J. Virol. Methods 110:67-71.
17. Maresova, L., L. Kutinova, V. Ludvikova, R. Zak, M. Mares, and S. Nem-eckova. 2000. Characterization of interaction of gH and gL glycoproteins of varicella-zoster vims: their processing and trafficking. J. Gen. Virol. 81:1545-1552.
18. McSharry, J. J. 2000. Analysis of virus-infected cells by flow cytometry. Methods 21:249-257.
19. Olson, J. K., G. A. Bishop, and C. Grose. 1997. Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J. Virol. 71:110-119.
20. Oxman, M. N., M. J. Levin, G. R. Johnson, K. E. Schmader, S. E. Straus, L. D. Gelb, R. D. Arbeit, M. S. Simberkoff, A. A. Gershon, L. E. Davis, A. Weinberg, K. D. Boardman, H. M. Williams, J. H. Y. Zhang, P. N. Peduzzi, C. E. Beisel, V. A. Morrison, J. C. Guatelli, P. A. Brooks, C. A. Kauffman, C. T. Pachucki, K. M. Neuzil, R. F. Betts, P. F. Wright, M. R. Griffin, P. Brunell, N. E. Soto, A. R. Marques, S. K. Keay, R. P. Goodman, D. J. Cotton, J. W. Gnann, J. Loutit, M. Holodniy, W. A. Keitel, G. E. Crawford, S. S. Yeh, Z. Lobo, J. F. Toney, R. N. Greenberg, P. M. Keller, R. Harbecke, A. R. Hayward, M. R. Irwin, T. C. Kyriakides, C. Y. Chan, I. S. F. Chan, W. W. B. Wang, P. W. Annunziato, and J. L. Silber. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352:2271-2284.
21. Panchision, D. M., H. L. Chen, F. Pistollato, D. Papini, H. T. Ni, and T. S. Hawley. 2007. Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133, CD15, and CD24. Stem Cells 25:1560-1570.
22. Pheasey, N., J. John, C. Love, R. Coffin, J. M. Ward, R. Boushaba, M. Hoare, and M. S. Levy. 2006. A capillary cytometer method to quantitate viable vims particles based on early detection of viral antigens and cellular events within single cells. J. Virol. Methods 137:213-218.
23. Redman, R. L., S. Nader, L. Zerboni, C. Liu, R. M. Wong, B. W. Brown, and A. M. Arvin. 1997. Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J. Infect. Dis. 176:578-585.
24. Rourou, S., A, van der Ark, T. van der Velden, and H. Kallel. 2007. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 25:3879-3889.
25. Searle, S. R., G. Casella, and C. E. McCullough. 1992. Variance components. John Wiley & Sons, Inc., New York, NY.
26. Shiraki, K., and M. Takahashi. 1982. Virus particles and glycoprotein excreted from cultured cells infected with varicella-zoster virus (VZV). J. Gen. Virol. 61(Pt2):271-275.
27. Tan, C. Y. 1999. M easurement-methods comparisons and linear statistical relationship. Technometries 41:192-201.
28. Tan, C. Y. 2005. RSD and other variability measures of the lognormal distribution. Pharmacopeial Forum 31:653-655.
29. Timbury, M. C, and E. Edmond. 1979. Herpesviruses. J. Clin. Pathol. 32: 859-881.
30. Wachs, F. P., S, Couillard-Despres, M. Engelhardt, D. Wilhelm, S. Ploetz, M. Vroemen, J. Kaesbauer, G. Uyanik, J. Klucken, C. Karl, J, Tebbing, C. Svendsen, N. Weidner, H, G. Kuhn, J. Winkler, and L, Aigner. 2003. High efficacy of clonal growth and expansion of adult neural stem cells. Lab. Investig. 83:949-962.
31. Wade, J. C. 2006. Viral infections in patients with hematological malignancies. Hematology Am. Soc. Hematol. Educ. Program 2006:368-374.
32. Weaver, L. S., and M. J. Kadan. 2000. Evaluation of adenoviral vectors by flow cytometry. Methods 21:297-312.
33. Weikert, C., M. Eppenberger-Eberhardt, and H. M. Eppenberger. 2003. Cellular engineering of ventricular adult rat cardiomyocytes. Cardiovasc. Res. 59:874-882.
34. Yamagishi, Y., T. Sadaoka, H. Yoshii, P. Somboonthum, T. Imazawa, K. Nagaike, K. Ozono, K. Yamanishi, and Y. Mori 2008. Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J. Virol. 82:795-804.